Summary.-Changes in cell mediated and humoral immunity following the excision of a transplantable melanoma growing in the footpad of its syngeneic host, as measured by an in vitro cytotoxicity test, were assessed. Spleen cell cytotoxicity did not change significantly. Cells from the regional lymph nodes stimulated tumour growth before tumour excision. Three days following tumour excision this stimulatory effect was undetectable. Loss of serum factors capable of blocking the cytotoxicity of spleen cells occurred 24 h after tumour excision. Serum cytotoxicity increased after tumour excision to a maximum on the third day. Following tumour excision the rise in serum cytotoxicity and loss of regional lymph node tumour stimulation were concomitant with the loss of blocking activity.
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SPECIFIC host immmunity to a growing tumour is now well documented using both in vivo (Prehn and Main, 1957; Klein et al., 1960) and in vitro (review, Hellstrom and Hellstr6m, 1971 ) methodology. Most studies show that both peripheral blood and splenic lymphocytes can inhibit tumour growth in vitro. This cell mediated immunity may be abrogated by sera from tumour bearing animals. It has also been demonstrated that the cell mediated immunity decreases and the serum blocking activity increases later in tumour growth (Hellstrom et al., 1973) .
However, recent reports on the role of the draining lymph node lymphocytes appear to be contradictory. Using a murine mammary tumour model, Medina and Heppner (1973) described tumour specific growth stimulation by lymphocytes derived from lymph nodes. Flannery et al. (1973) demonstrated that the regional lymph node cells exhibit early cytotoxicity which decreases late in tumour growth. Using a rat fibrosarcoma model, Currie and Gage (1973) reported continuing cytotoxicity in the regional lymph node cells, although there was a change from specific to nonspecific cytotoxicity later in tumour growth.
Tumour excision has been shown to effect an increase or return of cell mediated immunity with a decline in serum blocking factor (Heppner, 1972; Baldwin, Embleton and Robins, 1973) . Although Alexander et al. (1969) demonstrated immunoblast cells in the thoracic duct lymph after tumour removal, the effect of tumour excision on in vitro tumour growth stimulation by regional lymph node cells has not been described.
In a previous study using the mouse melanoma model, it was reported that spleen cell cytotoxicity was present at the same time as regional lymph node stimulation of tumour growth (Bartholomaeus et al., 1974 (Green, 1968 Serunm cytotoxicity. All sera were heat inactivated at 56°C for 30 min, diluted 1: 2 with culture medium and passed through an 0 45 ,um millipore filter. Normal guinea-pig serum, diluted 1: 5 in culture rnedium and sterilized by passage through a millipore filter was used as the source of complement. To determine serum cytotoxicity, 5 ,tl of medium containing B16 melanoma cells and 5 ,ul of serum w%ere incubated for 1 h at 37°C. 5 ,ul of com-plement was added and the trays were incubated at 37°C under 5% CO2 for 24 h and processed as described above.
Detection of blocking factors.-In experiments to test for the presence of serum factors capable of blocking the cytotoxicity of immune spleen cells against B16 melanoma cells, 5 ,ul of melanoma cells in culture medium and 5 ,ul of serum diluted 1: 2 in buffered RPMI were incubated at 37°C for 1 h before the addition of 5 ,ul of immune spleen cell suspension. The plates were incubated at 37°C under 5%o CO2 for 36 h and processed as described previously.
Experimental design.-Five animals from both control and tumour bearing groups were processed as described on Days 12, 22, 23, 25, 28 and 34 following inoculation of B16 melanoma. The control group consisted of sex and age-matched non-tumour bearing C57BL/6J mice. As foot amputation of control mice did not significantly change the cytotoxicity of cells from the regional lymph node or spleen in this test system, these animals were used as the source of normal cells and sera.
On Day 22, mice were anaesthetized with Nembutal and the left foot containing the tumour was amputated. At this stage the footpad had doubled in thickness. On Day 23 only sera were collected. The immune spleen cells used in blocking experiments were obtained from mice with a 22-day tumour. Cytotoxicity (relative inhibition of tumour cell growth in vitro) was expressed as a percentage, using the formula: Sera from tumour bearing mice were cytotoxic to melanoma cells compared with sera from control mice (Table II) .
Serum cytotoxicity increased from 27%0
pre-operatively to a maximum of 37% 3 days after excision of the tumour. The difference in serum cytotoxicity preoperatively to that 3 days post-operatively was significant (P < 0.01). Serum cytotoxicity was still present 12 days after tumour excision.
Sera from tumour bearing mice blocked the cytotoxicity of immune spleen cells in vitro (Table III) ; 24 h following tumour excision, this blocking effect was not observed and on Day 25, 3 days after tumour excision, the sera increased spleen cell cytotoxicity. This effect was still present 12 days post excision. Normal sera and sera from mice with a 1 cm diameter LLT did not block spleen cell cytotoxicity.
Ten mice from the experimental group were followed for 3 months and no evidence of recurrent tumour was observed.
DISCUSSION
In this experimental model rapid changes in the host immune response occurred when a growing tumour was excised. Most remarkable was the loss of blocking factor from the serum within 24 h. This was more rapid than previously reported. Baldwin et al.
(1]973) observed blocking to disappear at 3 days; Heppner (1972) showed a slower clearance in which blocking was more consistently absent 10-15 days after tumour excision. A likely explanation for the rapid loss of blocking in this study is that the tumours were excised when they were smaller than those used in the previous studies. Earlier work in this laboratory has shown that there was no spread of tumour to the regional lymph nodes or lungs at this stage of growth. As blocking activity is greatest with large tumour loads, it is thus likely to require a longer time for clearance following tumour excision.
No direct evidence as to the nature of the blocking factor has been elucidated in this study. It would be most unlikely Currie and Basham (1972) . The rise in cytotoxic antibody titre following tumour excision may have been due to a continuing antibody production in the absence of tumour cells which could have bound the antibody or which could have released antigen into the circulation with the formation of antigenantibody complexes. Because low antibody titres were found in the thoracic duct lymph of tumour bearing animals, Thompson, Steele and Alexander (1973) considered that antigen was released from the tumour cell before being bound by antibody. The rise in antibody titre may enable residual tumour cells to be destroyed either directly by fixing complement or by activating a cell mediated response (Basham and Currie, 1, 974) .
On the basis of in vivo studies, Prehn (1972) has postulated that a weak cell mediated immunity may directly stimulate tumour growth. In vitro evidence for " immunostimulation " has recently been reported (Medina and Heppner, 1972; Fidler, 1973; Bartholomaeus et al., 1974) in lymph node lymphocytes. Flannery et al. (1973) , using a rat squamous cell carcinoma, demonstrated regional lymph node cytotoxicity that disappeared with tumour growth, although peripheral lymphocyte cytotoxicity was still present. They attributed the loss of cytotoxicity to increased levels of blocking factor acting in association with an increase in tumour growth. It is possible that a similar mechanism is operative in this experimental model as lymph node stimulation of tumour growth by regional lymph node cells disappeared following the loss of serum blocking factor after the tumour was excised.
It is not considered that the regional lymph node lymphocytes directly stimulate tumour cell growth in vitro. A more reasonable explanation is that the regional lymph node cells have attached blocking factor which is not removed by the conventional 3 washings in PBS as previously demonstrated by Currie and Basham (1972) in patients with advanced tumour growth. In tissue culture this blocking factor inhibits lymphocyte reactivity. However, as the control lymph node cells reduce the number of melanoma cells in each tissue culture well over the 36 h incubation period, the net result is an apparent stimulation of tumour growth.
These findings provide in vitro evidence to support the work of Alexander et al. (1969) . They found that the regional lymph node appeared quite active histologically, although there were no increased numbers of immunoblasts in the draining lymph. After tumour excision there was a rapid rise of immunoblasts in the lymph while the regional lymph nodes returned to a normal histological appearance. The suggestion that tumour antigen produced a selective depression on the regional lymph nodes' responsiveness would agree with current views on the nature of blocking (Currie, 1973) and results obtained from this study.
It would appear that the changes in host immunity observed are directly related to removal of the source of tumour antigen, leading to loss of serum blocking and a rise in serum cytotoxicity. Associated with the loss of high concentrations of blocking factor locally, regional lymph node stimulation of tumour growth disappeared. If these in vitro findings are directly applicable to the in vivo situation, it would suggest that tumour excision confers a number of beneficial effects on the host; the major effect being loss of serum blocking factor in the presence of a continuing cell mediated immunity inhibitory to tumour cell growth. 
